[
    {
        "file_name": "KINGPHARMACEUTICALSINC_08_09_2006-EX-10.1-PROMOTION AGREEMENT.txt",
        "perturbation": [
            {
                "type": "Misaligned Terminology - In Text Contradiction",
                "original_text": "King shall refer any oral or written Product Complaints which it receives concerning the Product to Depomed within four calendar days of its receipt thereof; provided, that all complaints concerning suspected or actual Product tampering, contamination or mix-up shall be delivered within twenty-four hours of its receipt thereof. King shall not take any other action in respect of any such complaint without the consent of Depomed unless otherwise required by Legal Requirements.",
                "changed_text": "King shall refer any oral or written Product Complaints which it receives concerning the Product to Depomed within four calendar days of its receipt thereof; provided, that all notifications concerning suspected or actual Product tampering, contamination or mix-up shall be delivered within seventy-two hours of its receipt thereof. King shall take actions to resolve such complaints in accordance with standard industry practice without the consent of Depomed unless otherwise required by Legal Requirements.",
                "explanation": "The term 'Product Complaints' is used interchangeably with 'notifications', but the timeframe for reporting tampering is changed from 24 to 72 hours. Furthermore, King is now allowed to resolve complaints without Depomed's consent, creating conflicting obligations.",
                "location": "Section 5.5"
            },
            {
                "type": "Misaligned Terminology - In Text Contradiction",
                "original_text": "In the event that a Depomed Supply Failure occurs, notwithstanding its compliance with its obligations under Section 6.1, to fulfill all orders for the Product generated by King activities in a timely and efficient manner, upon written notice to Depomed (a \"King Manufacturing Notice\"), King shall have, and hereby grants King, exercisable only in accordance with the provisions hereof, the right, but not the obligation, to manufacture, or have manufactured, the Product on behalf of Depomed, at Depomed's expense, including expenses related to the technical transfer of the Product, and Depomed will provide reasonable assistance to King in connection therewith, including by transferring or licensing to King all Technology necessary or useful to give King the capability of manufacturing the Product so that King can undertake manufacture of the Product; provided, however, that Depomed shall not be required to reimburse King for more than [***] percent ([***]%) of Depomed's standard cost for such Product. Any such Product manufactured by King will be sold by Depomed in accordance with this Agreement.",
                "changed_text": "In the event that a Depomed Supply Interruption occurs, notwithstanding its compliance with its obligations under Section 6.1, to fulfill all orders for the Product generated by King activities in a timely and efficient manner, upon written notice to Depomed (a \"King Manufacturing Notice\"), King shall have, and hereby grants King, exercisable only in accordance with the provisions hereof, the right, but not the obligation, to manufacture, or have manufactured, the Product on behalf of Depomed, at Depomed's expense, including expenses related to the technical transfer of the Product, and Depomed will provide reasonable assistance to King in connection therewith, including by transferring or licensing to King all Technology necessary or useful to give King the capability of manufacturing the Product so that King can undertake manufacture of the Product; provided, however, that Depomed shall not be required to reimburse King for any expenses related to such manufacture. Any such Product manufactured by King will be used for research purposes only.",
                "explanation": "The term 'Depomed Supply Failure' is replaced with 'Depomed Supply Interruption,' and the reimbursement clause is removed entirely. Also it states that products manufactured by King will be for research only.",
                "location": "Section 6.6"
            },
            {
                "type": "Misaligned Terminology - In Text Contradiction",
                "original_text": "In consideration for King's performance of its obligations under this Agreement, Depomed shall pay promotion fees (the \"Promotion Fees\") to King as follows: following each Agreement Quarter during the Term, Depomed shall pay to King 50% of the Gross Margin for such Agreement Quarter.",
                "changed_text": "In consideration for King's performance of its obligations under this Agreement, Depomed may provide compensation (the \"Consideration\") to King as follows: following each Fiscal Year during the Term, Depomed will evaluate whether to provide any monetary benefit to King.",
                "explanation": "The term 'Promotion Fees' is replaced with 'Consideration,' changing the nature of the payment from mandatory to discretionary and changing the frequency of payment.",
                "location": "Section 7.1(a)"
            }
        ]
    }
]